Company Filing History:
3 out of 8,373 
2 out of 2 
1 out of 1 Years Active: 2022-2024
Title: David Jin: Innovator in Fc Fusion Receptor Proteins
Introduction
David Jin is a notable inventor based in Staten Island, NY (US), recognized for his contributions to the field of biotechnology. He holds three patents that focus on innovative receptor fusion proteins, which have significant implications in medical research and treatment.
Latest Patents
Among his latest patents, the first is titled "QTY Fc Fusion Receptor Proteins." This invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, along with methods for their preparation and use. The second patent, "QTY FC Fusion Water Soluble Receptor Proteins," also focuses on QTY Fc receptor fusion proteins, detailing methods for their preparation and applications.
Career Highlights
David Jin has worked with prestigious organizations, including the Massachusetts Institute of Technology and Avalon Globocare Corporation. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in his field.
Collaborations
Some of his notable coworkers include Shuguang Zhang and Rui Qing, who have collaborated with him on various projects, enhancing the scope and impact of their research.
Conclusion
David Jin's work in Fc fusion receptor proteins exemplifies the innovative spirit of modern biotechnology. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving medical applications.